Deborah Slipetz
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Asthma and respiratory diseases, Inflammatory mediators and NSAID effects, Neuropeptides and Animal Physiology, Cannabis and Cannabinoid Research
Most-Cited Works
- → Cloning and expression of a cDNA for the human prostanoid FP receptor.(1994)385 cited
- → Molecular Cloning and Characterization of the Human Prostanoid DP Receptor(1995)334 cited
- → Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes(1997)298 cited
- → Cloning and expression of a cDNA for the human prostanoid IP receptor.(1994)197 cited
- → Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.(1995)194 cited
- → Discovery of a Potent and Selective Prostaglandin D2 Receptor Antagonist, [(3R)-4-(4-Chloro- benzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic Acid (MK-0524)(2007)170 cited
- → The Yeast KRE5 Gene Encodes a Probable Endoplasmic Reticulum Protein Required for (1→6)-β-D-Glucan Synthesis and Normal Cell Growth(1990)137 cited
- → Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers(2012)136 cited
- → Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors(1996)107 cited
- → New class of potent ligands for the human peripheral cannabinoid receptor(1996)97 cited